StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)

Close on Nov 17, 2026Market cap $304.70MP/E –Yield –

MapLight Therapeutics cash

Cash and short-term investments held at the end of each period.

MapLight Therapeutics's cash was $304.73M at Jun 30, 2026. For fiscal 2025 it was $453.10M, up 316.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$453.10M+316.5%
FY2024Dec 31, 2024$108.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$304.73M+180.1%
Q1 FY2026Mar 31, 2026$310.11M–
Q4 FY2025Dec 31, 2025$453.10M–
Q3 FY2025Sep 30, 2025$227.20M–
Q4 FY2024Dec 31, 2024$108.80M–

More MapLight Therapeutics figures

See a number that looks wrong?